The efficacy and safety of omalizumab in refractory chronic spontaneous urticaria: real-life experience in Turkey

Bulur I., BÜLBÜL BAŞKAN E., Ozdemir M., Balevi A., Goncu E. K., Altunay I., ...Daha Fazla

ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA, cilt.27, sa.3, ss.121-126, 2018 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 27 Sayı: 3
  • Basım Tarihi: 2018
  • Doi Numarası: 10.15570/actaapa.2018.25
  • Dergi Adı: ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
  • Sayfa Sayıları: ss.121-126
  • Anahtar Kelimeler: chronic spontaneous urticaria, omalizumab, dermatology life quality, UAS(7), side effects, QUALITY-OF-LIFE, INDUCIBLE URTICARIA, DISEASE-ACTIVITY, THERAPY, VALIDATION, MANAGEMENT, INDEX, IGE
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Introduction: This study used real-world data to evaluate the effectiveness and reliability of omalizumab in treating recalcitrant chronic spontaneous urticaria in Turkish patients.